Resources
About Us
Home Report
Store
Continuous Glucose Monitoring Market
Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics) - Global Forecast to 2031
Report ID:MRHC - 1041277 Pages: 150 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursContinuous Glucose Monitoring Market
The Continuous Glucose Monitoring Market is expected to reach $31.41 billion by 2031, at a CAGR of 15% from 2024 to 2031. The growth of this market is driven by factors such as the increasing prevalence of diabetes and the number of people living a sedentary lifestyle, the benefits of CGM over conventional glucose monitoring, and the use of CGM by athletes and fitness enthusiasts. Furthermore, technological advancements in CGM devices, a shift toward personalized care and rising health awareness, and increasing accessibility for diabetes care devices in low and middle-income countries are expected to offer growth opportunities for the players operating in the continuous glucose monitoring market.
Continuous Glucose Monitoring Market Growth Drivers
Increasing Prevalence of Diabetes
Continuous glucose monitors help measure glucose levels in the body and send the readings to the healthcare provider through a smartphone app. Several new products have been launched in the diabetes management space in recent years; for instance, in March 2024, the U.S. Food and Drug Administration (FDA) approved DexCom, Inc.’s (U.S.) Dexcom Stelo Glucose Biosensor System. It is an over-the-counter (OTC) integrated CGM and can be used for patients aged 18 years and older. This device is suitable for people who are not on insulin and who do not have severe hypoglycemia.
Some of the risk factors of diabetes are obesity, family history, poor diet, mutations in single gene, prediabetes, sedentary lifestyle, and insulin resistance.
For instance, according to the World Health Organization (WHO), approximately 422 million people have diabetes worldwide. Continuous glucose monitoring helps patients regularly monitor their glucose levels and receive timely alerts in case of low or high glucose levels.
Click here to: Get Free Sample Pages of this Report
Benefits of CGM Over Conventional Glucose Monitoring
The rising incidence of chronic diseases enabled technological advancements in healthcare devices. One such advancement is the growing use of continuous glucose monitors. The benefits offered by CGMs over conventional devices are real-time data monitoring; provision of trend analysis to monitor glucose levels during meals, exercise, and resting periods of the patient; issue alerts in cases of extremely high or low glucose levels, enhanced diabetes management, and reduction in the use of fingerstick.
Artificial intelligence (AI) is also being integrated into CGM devices contributing to effective diabetes management. This integration leads to the optimization of treatments and helps in lifestyle management to avoid the risk of diabetes. For instance, in May 2023, January, Inc. (U.S.) launched a generative artificial intelligence (AI) supported app that can estimate and predict the glucose patterns of individuals. This app can be integrated with a CGM and can be accessed through any smartphone device to receive recommendations on calorie intake and physical activity. It also offers tips on blood glucose management and can be used by people without diabetes who are on special diets such as intermittent fasting.
Continuous Glucose Monitoring Market Trends
Shift Toward Smart Devices and Advanced Healthcare with Artificial Intelligence
The usage of smart electronic devices and the integration of AI in glucose monitoring is a recent development. Smart CGM devices predict fluctuations in glucose levels up to 60 minutes in advance and provide access to additional algorithms and insights for improved glucose management. For example, the Guardian Connect CGM System, developed by Medtronic (Ireland), allows users with diabetes to track their glucose patterns on mobile devices every 5 minutes.
AI integration in glucose monitoring devices helps reduce manual checking of blood glucose levels by predicting the sugar levels and creating a personalized plan, making diabetes management easier than with traditional devices. For instance, in March 2024, Roche launched an AI-powered diabetes management system called the 14-day Accu-Chek SmartGuide system that predicts fluctuations in glucose levels.
Growing Adoption of Wearable Devices
After the COVID-19 pandemic, there has been increased adoption of wearable technology in healthcare. The rising prevalence of diabetes and an increased need for real-time or continuous monitoring are key drivers of this increasing adoption. CGM devices have a lower turnaround time than the conventional process at the clinics, which is expensive and relies on patient-provider availability.
The adoption of wearable devices to monitor vitals has proven to be significant. Additionally, the emphasis on preventive healthcare and personalized medicine is encouraging more people to adopt CGM devices to manage their health proactively.
Continuous Glucose Monitoring Market Opportunity
Technological Advancements in CGM Devices
Technologically advanced continuous glucose monitors are gaining popularity due to the enhanced connectivity features offered by these devices. Some of the advantages offered by these devices include wireless connectivity, personalized glucose level tracking, integration with insulin pumps, and a combination of artificial intelligence and machine learning.
Another such innovation is the use of enzyme-based electrochemical sensors in CGM devices that provide accurate and reliable information to the users. Many of the minimally invasive CGM systems are enzyme-based. The wireless connectivity feature of CGMs with smartphones enables users to track their glucose levels in real time. Combining this with insulin pumps allows the adjustment of insulin levels based on glucose levels, providing a significant edge in diabetes care management.
Additionally, implantable continuous glucose monitors are also being introduced. For instance, in February 2022, Senseonics Holdings, Inc. (U.S.) received the U.S. Food and Drug Administration (FDA) approval for the Eversense® E3 version, which is an implantable CGM device and can stay in the body of a patient for approximately six months.
Continuous Glucose Monitoring Market Analysis: Key Findings
By Component: In 2024, the Sensors Segment to Dominate the Continuous Glucose Monitoring Market
Based on component, the continuous glucose monitoring market is segmented into sensors, transmitters, and receivers. In 2024, the sensors segment is expected to account for the largest share of over 52.4% of the continuous glucose monitoring market. The rise in the preference for continuous glucose monitoring, along with frequent purchases of sensors, compared to receivers and transmitters, supports the large market share of this segment. Sensors require more frequent replacement compared to other components. Disposable sensors are replaced in 7 to 14 days after placement while implantable sensors can be replaced in 150-180 days.
By Age Group: In 2024, the Adults Segment to Dominate the Continuous Glucose Monitoring Market
Based on age group, the market is segmented into adults and children. In 2024, the adult segment is expected to account for a larger share of the continuous glucose monitoring market. This segment’s large market share can be attributed to the rise in the geriatric population with a high prevalence of diabetes and a sedentary lifestyle, leading to diseases such as obesity. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in 2021, 38.4 million people of all ages had diabetes (11.6% of the population), among which 38.1 million were adults ages 18 years or older.
However, the children segment is projected to register the highest growth rate during the forecast period. Children are more likely to get diagnosed with type 1 diabetes, where the body no longer produces insulin, leading to elevated glucose levels. For instance, according to the International Diabetes Federation (IDF) Atlas 2022, in 2022, there were 1.52 million under 20 years of age, living with type 1 diabetes globally. Continuous or real-time monitoring of glucose levels can help effectively manage this condition.
By End User: in 2024, the Home Care Settings Segment to Dominate the Continuous Glucose Monitoring Market
Based on end user, the market is segmented into home care settings and medical facilities such as hospitals & clinics. In 2024, the home care settings segment is expected to account for a larger share of over 82.3% of the continuous glucose monitoring market. The large market share of this segment is attributed to factors such as the rising prevalence of diabetes globally, increasing health awareness among people, a shift toward preventive healthcare, and easy accessibility to CGM in developed countries. CGM technologies provide numerous benefits in home care settings. There is a growing shift toward home healthcare due to the shortage of healthcare professionals and increasing consumer awareness about the monitoring of diabetic conditions through CGM.
Geographical Analysis
In 2024, North America to Dominate the Continuous Glucose Monitoring Market
In 2024, North America is expected to account for the largest share of over 42.2% of the continuous glucose monitoring market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America’s significant market share can be attributed to the high accessibility to advanced technologies, the presence of prominent manufacturers in the region, significant investments in research & development, a robust reimbursement framework for continuous glucose monitoring devices, and supportive government initiatives aimed at raising awareness about diabetes. According to the Centers for Medicare and Medicaid Services (U.S.), in 2022, healthcare spending was 4.1 percent, reaching $4.5 trillion or $13,493 per person.
However, the market in Asia-Pacific is projected to register the highest CAGR of over 17.40% during the forecast period. The growth of this regional market is driven by factors such as improving healthcare infrastructure, rising disposable income, and increasing investments by major market players. Furthermore, economic growth, as well as technological advancements are the major reasons for market growth in this region.
Continuous Glucose Monitoring Market: Key Companies
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and the key growth strategies adopted by them over the past three to four years. Some of the key players operating in the continuous glucose monitoring market are DexCom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic PLC (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (Maryland), A. Menarini Diagnostics S.r.l (Italy), Medtrum Technologies, Inc. (Shanghai.), and B. Braun SE (Germany).
Continuous Glucose Monitoring Industry Overview: Latest Developments from Key Industry Players
- In February 2024, DexCom, Inc. (U.S.) launched Dexcom ONE+ in Spain, Belgium, and Poland. It is a customizable continuous glucose monitoring solution consisting of a wearable sensor, a transmitter, and a smartphone-compatible app. The device can be worn on three sites in the body. The water-resistant sensor measures blood glucose levels and sends these CGM readings to smartphones compatible with the Dexcom One application.
- In December 2023, the International Diabetes Federation (IDF) partnered with FIND (Foundation for Innovative New Diagnostics) (Switzerland), a global health non-profit organization, to advance capacity building in CGM technology for healthcare providers and people living with diabetes. This collaboration is a part of the project ACCEDE (ACcess to CGMs for Equity in DiabEtes management), which aims to enhance diabetes management and the use of CGMs in low and middle-income countries, mainly Kenya and South Africa.
Continuous Glucose Monitoring Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
150 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
15% |
|
Market Size (Value) |
$31.41 Billion by 2031 |
|
Segments Covered |
By Component
By Age Group
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Norway, Sweden, Denmark, Belgium, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
|
Key Companies |
DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum. Technologies, Inc. (Shanghai.), B. Braun SE (Germany) |
Key questions answered in the continuous glucose monitoring market report:
This market study covers the market sizes and forecasts of the continuous glucose monitoring market based on component, age group, end user, and geography. This market study also provides the value analysis of various segments and sub-segments of the continuous glucose monitoring market at the regional and country levels.
The continuous glucose monitoring market is projected to reach $31.41 billion by 2031, at a CAGR of 15% during the forecast period.
The sensors segment is expected to account for the largest share of the continuous glucose monitoring market in 2024. The large market share of this segment is attributed to factors such as a rise in the preference for continuous glucose monitoring coupled with frequent purchases of sensors compared to receivers and transmitters.
The growth of this market is driven by factors such as the increasing prevalence of diabetes across all age groups, the increasing number of people living sedentary lifestyles as well as the use of CGM by athletes and fitness enthusiasts. Furthermore, technological advancements in CGM devices, a shift toward personalized care along with rising health awareness, benefits offered by CGM over conventional glucose monitoring, and increasing accessibility for diabetic care devices in low- and middle-income countries are expected to provide growth opportunities for the market.
The key players profiled in the continuous glucose monitoring market report are DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic PLC (Ireland), Nemaura Medical Inc. (U.K.), LifeScan, Inc. (U.S.), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum Technologies, Inc. (Shanghai.), and B. Braun SE (Germany).
China, South Korea, and India are expected to offer significant growth opportunities for the vendors in the continuous glucose monitoring market during the analysis period. The rising incidence of diabetes in China and India, rising healthcare spending, and expansion of CGM manufacturing facilities are expected to drive the market’s growth in these countries.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Diabetes
4.2.2. Increasing Number of People Living Sedentary Lifestyle
4.2.3. Benefits of CGM over Conventional Glucose Monitoring
4.2.4. Use of CGM by Athletes and Fitness Enthusiasts
4.3. Restraints
4.3.1. High Cost of CGM Devices
4.3.2. Product Recalls
4.4. Opportunities
4.4.1. Technological Advancements in CGM Devices
4.4.2. Shift Toward Personalized Care and Rising Health Awareness
4.4.3. Increasing Accessibility for Diabetes Care Devices in Low- and Middle-income Countries
4.5. Challenges
4.5.1. High Proportion of Undiagnosed Diabetes Population
4.5.2. Issues Related to Adhesiveness, Reliability, and Accuracy of CGM Devices
4.6. Technology Trends/Market Trends
4.6.1. Shift Toward Smart Devices and Advanced Healthcare with Artificial Intelligence
4.6.2. Growing Adoption of Wearable Devices
4.6.3. Growing Demand for Non-invasive CGM Devices
4.7. Regulatory Scenarios
4.8. Pricing Analysis
4.9. Case Studies
4.10. Porter’s Five Forces Analysis
5. Continuous Glucose Monitoring Market—by Component
5.1. Overview
5.2. Sensors
5.2.1. Disposable Sensors
5.2.2. Implantable Sensors
5.3. Transmitters
5.4. Receivers
6. Continuous Glucose Monitoring Market—by Age Group
6.1. Overview
6.2. Adults
6.3. Children
7. Continuous Glucose Monitoring Market—by End User
7.1. Overview
7.2. Home Care Settings
7.3. Hospitals & Clinics
8. Continuous Glucose Monitoring Market—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Norway
8.3.7. Sweden
8.3.8. Denmark
8.3.9. Belgium
8.3.10. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. South Korea
8.4.5. Rest of Asia Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competitive Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Market Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Ranking, by Key Players (2023)
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
10.1. DexCom, Inc.
10.2. Abbott Laboratories
10.3. F. Hoffmann-La Roche Ltd
10.4. Medtronic plc
10.5. Nemaura Medical Inc.
10.6. i-Sens, Inc.
10.7. LifeScan, Inc.
10.8. Senseonics Holdings, Inc.
10.9. A. Menarini Diagnostics S.r.l
10.10. Medtrum Technologies, Inc.
10.11. B. Braun SE
10.12. Other Companies
(Note: SWOT Analysis will be Provided for The Top 5 Players)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 2 Global Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 3 Global Continuous Glucose Monitoring Sensors Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Disposable Continuous Glucose Monitoring Sensors Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Implantable Continuous Glucose Monitoring Sensors Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Continuous Glucose Monitoring Transmitters Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Continuous Glucose Monitoring Receivers Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 9 Global Continuous Glucose Monitoring Market for Adults, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Continuous Glucose Monitoring Market for Children, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 12 Global Continuous Glucose Monitoring Market for Home Care Settings, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Continuous Glucose Monitoring Market for Hospitals/Clinics, by Country/Region, 2022–2031 (USD Million
Table 14 Global Continuous Glucose Monitoring Market, by Country/Region, 2022–2031 (USD Million)
Table 15 North America: Continuous Glucose Monitoring Market, by Country, 2022–2031 (USD Million)
Table 16 North America: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 17 North America: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 18 North America: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 19 North America: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 20 U.S.: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 21 U.S.: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 22 U.S.: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 23 U.S.: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 24 Canada: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 25 Canada: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 26 Canada: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 27 Canada: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 28 Europe: Continuous Glucose Monitoring Market, by Country/Region, 2022–2031 (USD Million)
Table 29 Europe: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 30 Europe: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 31 Europe: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 32 Europe: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 33 Germany: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 34 Germany: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 35 Germany: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 36 Germany: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 37 France: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 38 France: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 39 France: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 40 France: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 41 U.K.: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 42 U.K.: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 43 U.K.: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 44 U.K.: Continuous Glucose Monitoring Market, by End Users, 2022–2031 (USD Million)
Table 45 Italy: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 46 Italy: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 47 Italy: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 48 Italy: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 49 Spain: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 50 Spain: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 51 Spain: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 52 Spain: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 53 Norway: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 54 Norway: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 55 Norway: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 56 Norway: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 57 Sweden: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 58 Sweden: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 59 Sweden: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 60 Sweden: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 61 Denmark: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 62 Denmark: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 63 Denmark: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 64 Denmark: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 65 Belgium: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 66 Belgium: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 67 Belgium: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 68 Belgium: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 69 Rest of Europe: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 70 Rest of Europe: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 71 Rest of Europe: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 72 Rest of Europe: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 73 Asia-Pacific: Continuous Glucose Monitoring Market, by Country/Region, 2022–2031 (USD Million)
Table 74 Asia-Pacific: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 75 Asia-Pacific: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 76 Asia-Pacific: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 77 Asia-Pacific: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 78 Japan: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 79 Japan: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 80 Japan: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 81 Japan: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 82 China: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 83 China: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 84 China: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 85 China: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 86 India: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 87 India: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 88 India: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 89 India: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 90 South Korea: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 91 South Korea: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 92 South Korea: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 93 South Korea: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 94 Rest of Asia-Pacific: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 95 Rest of Asia-Pacific: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 96 Rest of Asia-Pacific: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 97 Rest of Asia-Pacific: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 98 Latin America: Continuous Glucose Monitoring Market, by Country/Region, 2022–2031 (USD Million)
Table 99 Latin America: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 100 Latin America: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 101 Latin America: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 102 Latin America: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 103 Brazil: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 104 Brazil: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 105 Brazil: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 106 Brazil: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 107 Mexico: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 108 Mexico: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 109 Mexico: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 110 Mexico: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 111 Rest of Latin America: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 112 Rest of Latin America: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 113 Rest of Latin America: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 114 Rest of Latin America: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 115 Middle East & Africa: Continuous Glucose Monitoring Market, by Component, 2022–2031 (USD Million)
Table 116 Middle East & Africa: Continuous Glucose Monitoring Sensors Market, by Type, 2022–2031 (USD Million)
Table 117 Middle East & Africa: Continuous Glucose Monitoring Market, by Age Group, 2022–2031 (USD Million)
Table 118 Middle East & Africa: Continuous Glucose Monitoring Market, by End User, 2022–2031 (USD Million)
Table 119 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Continuous Glucose Monitoring Market, by Component, 2024 Vs. 2031 (USD Million)
Figure 8 Global Continuous Glucose Monitoring Market, by Age Group, 2024 Vs. 2031 (USD Million)
Figure 9 Global Continuous Glucose Monitoring Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 10 Global Continuous Glucose Monitoring Market, by Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 Global Continuous Glucose Monitoring Market, by Component, 2024 Vs. 2031 (USD Million)
Figure 13 Global Continuous Glucose Monitoring Market, by Age Group, 2024 Vs. 2031 (USD Million)
Figure 14 Global Continuous Glucose Monitoring Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 15 Global Continuous Glucose Monitoring Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 16 North America: Continuous Glucose Monitoring Market Snapshot
Figure 17 Europe: Continuous Glucose Monitoring Market Snapshot
Figure 18 Asia-Pacific: Continuous Glucose Monitoring Market Snapshot
Figure 19 Latin America: Continuous Glucose Monitoring Market Snapshot
Figure 20 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 21 Global Continuous Glucose Monitoring Market: Competitive Benchmarking, by Component
Figure 22 Global Continuous Glucose Monitoring Market: Competitive Dashboard
Figure 23 Global Continuous Glucose Monitoring Market: Market Share Analysis/Market Ranking (2023)
Figure 24 Abbott Laboratories: Financial Overview (2023)
Figure 25 F. Hoffmann-La Roche Ltd: Financial Overview (2023)
Figure 26 Medtronic plc: Financial Overview (2023)
Figure 27 Nemaura Medical Inc.: Financial Overview (2023)
Figure 28 i-Sens, Inc.: Financial Overview (2023)
Figure 29 Senseonics Holdings, Inc.: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Europe Continuous Bioprocessing Market - Opportunity Analysis And Industry Forecast (2024-2030)
Published Date: Jul-2024
Continuous Bioprocessing Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Mar-2024
Point of care Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: May-2023
